DeutschNewstral
Article
bizjournals.com on 2021-10-08 15:12
Pharma giant Gilead Sciences considered Atlanta before selecting Raleigh for 275-job expansion
Related news
- Pharma giant Gilead Sciences considered Durham before selecting Raleigh for 275 jobsbizjournals.com
- Gilead Sciences considered Atlanta, Durham before selecting Raleigh for 275 jobsbizjournals.com
Gilead Sciences Is OversoldForbes- Oversold Conditions For Gilead SciencesForbes
- KTenofovir/Alafenamide Compound Drugs Market Size and Growth 2021-2027 | Top Companies – Gilead Sciences, Cipla, Mylan Pharmaceuticals, Natco Pharma, Sun Pharmaceutical Industries, Beacon Pharmaceuticals, Julphar Bangladesh, .ksusentinel.com
- CGilead Sciences beats forecasts on higher salescontracostatimes.com
AstraZeneca eyes potential merger with Gilead SciencesNew York Post- SGilead Sciences shares fall after replacing CEOsiliconbeat.com
- MGilead Sciences names Kevin Young COOmarketwatch.com
- CGilead Sciences beats Street 3Q forecastscontracostatimes.com
FDA approves Gilead Sciences’ remdesivir for coronaviruspressherald.com- MGilead Sciences, 'flooded' by demand for redesivir, halts compassionate usemarketwatch.com
- Coronavirus patients eagerly join Gilead Sciences drug studyNew York Post
- BGilead Sciences Stock Is Moving Back Into Favorbarrons.com
- Gilead Sciences to start testing inhaled version of remdesivirNew York Post
Coronavirus: Stocks rally on Gilead Sciences’ upbeat treatment reportSan Jose Mercury News- IShould I buy Gilead Sciences shares in November 2022?invezz.com
- CGilead Sciences halts drug studies over side effects, deathcontracostatimes.com
- Robin L. Washington of Gilead Sciences, Lifetime Achievement Award Winnerbizjournals.com
Gilead Sciences buying Forty Seven for $4.9 billionbradenton.com